MARKET

RENXF

RENXF

Renalytix Plc
OTCMQB
0.088
NaN%
Closed 09:30 10/23 EDT
OPEN
--
PREV CLOSE
0.088
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.163
52 WEEK LOW
0.023
MARKET CAP
58.80M
P/E (TTM)
-1.6705
1D
5D
1M
3M
1Y
5Y
1D
Renalytix Set to Benefit as U.S. Kidney Care Plan Backs Precision Prevention
TipRanks · 3d ago
Renalytix Director Christopher Mills Increases Shareholding After Equity Placing
TipRanks · 10/02 15:12
Renalytix Director Lifts Stake as AI Kidney Test Gains Commercial Traction
TipRanks · 10/01 15:13
Renalytix Shareholders Back Fundraising as New Shares Join AIM
TipRanks · 09/28 11:53
Renalytix Chair to Step Down as Company Advances U.S. Kidney Test Rollout
TipRanks · 09/28 06:07
Renalytix boosts investor engagement as KidneyIntelX gains commercial traction
TipRanks · 09/25 13:02
Renalytix CEO Increases Stake as AI Kidney Test Gains U.S. Traction
TipRanks · 09/16 10:07
Renalytix Aligns Year-End Reporting With Calendar Year Ahead of Quest Partnership
TipRanks · 09/14 09:12
More
About RENXF
Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Webull offers Renalytix PLC stock information, including OTCMQB: RENXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RENXF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RENXF stock methods without spending real money on the virtual paper trading platform.